Papel de los anti-pd1 en el abordaje de un paciente diagnosticado con melanoma

10 / 40

Overall Survival<br />Median Follow-Up 45.9 (0.3-50.0) Months
Presented By Georgina Long at 2018 ASCO Annual Meeting